Evidence map›Paper›PMID 32016361›Full record

ArticleBrain : a journal of neurology2020

Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

Pascual Torres, Pol Andrés-Benito, Anna Fernàndez-Bernal, Marta Ricart, Victòria Ayala, Reinald Pamplona, Isidro Ferrer, Manuel Portero-Otin

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Loss of Nuclear TDP-43 Impairs Lipid Metabolism in Microglia-Like Cells.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pascual TorresDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Pol Andrés-BenitoDepartment of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
Anna Fernàndez-BernalDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Marta RicartDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Victòria AyalaDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Reinald PamplonaDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Isidro FerrerDepartment of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain.
Manuel Portero-OtinDepartment of Experimental Medicine, IRBLleida, University of Lleida, Lleida, Spain.
Universitat de Lleida · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseCell NucleusConsensusDNA-Binding ProteinsExonsHippocampusHumansTDP-43 ProteinopathiesDNA-Binding ProteinsTARDBP protein, human

Identifiers

PMID32016361
OpenAlexW3005548498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.